Trial Profile

PREmier of randomized COMparison of bypass surgery versus AngioplasTy using sirolimus-eluting stent in patients with left main coronary artery disease

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 09 Feb 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sirolimus (Primary)
Indications Acute coronary syndromes; Coronary artery disease; Coronary artery restenosis
Focus Therapeutic Use
Acronyms PRE-COMBAT

Most Recent Events

06 Sep 2016 Results (n=1305) of a pooled analysis of individual patient-level data from SYNTAX and PRECOMBAT trials, published in the Journal of the American College of Cardiology
30 Apr 2014 Status changed from active, no longer recruiting to completed.
20 Aug 2012 Actual patient number changed from 600 to 1454 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com